PROPETANDROL

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C23H36O3
Molecular Weight	360.5301
Optical Activity	UNSPECIFIED
Defined Stereocenters	7 / 7
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CCC(=O)O[C@H]1CC[C@@H]2[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)CC)[C@@H]3CCC2=C1

InChI

InChIKey=ODOMHABFTBNARE-JSDYAUHVSA-N

InChI=1S/C23H36O3/c1-4-21(24)26-16-7-9-17-15(14-16)6-8-19-18(17)10-12-22(3)20(19)11-13-23(22,25)5-2/h14,16-20,25H,4-13H2,1-3H3/t16-,17-,18+,19+,20-,22-,23-/m0/s1

HIDE SMILES / InChI

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13478436 | https://www.ncbi.nlm.nih.gov/pubmed/13817884 | https://www.ncbi.nlm.nih.gov/pubmed/17732403 | https://www.ncbi.nlm.nih.gov/pubmed/14329833

Propetandrol is a pregnanediol derivative patented by Schering A.-G. as long-acting anabolic androgen. Propetandrol is potent in the prevention of tissue calcification and skeletal lesions.

Originator

Approval Year

PubMed

Title	Date	PubMed
The duration of action of several androgenic-anabolic steroids.	1957-11	13478436

Patents

Name

Type

Language

PROPETANDROL

Official Name

English

SC-7294

Preferred Name

English

19-NOR-17.ALPHA.-PREGN-4-ENE-3.BETA.,17-DIOL 3-PROPIONATE

Common Name

English

propetandrol [INN]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C2360